Search

Author/Creator Perl, A.

4. S100: QUIZARTINIB PROLONGED SURVIVAL VS PLACEBO PLUS INTENSIVE INDUCTION AND CONSOLIDATION THERAPY FOLLOWED BY SINGLE-AGENT CONTINUATION IN PATIENTS AGED 18-75 YEARS WITH NEWLY DIAGNOSED FLT3-ITD+ AML. (23rd June 2022)

Authors:
Erba, H.; Montesinos, P.; Vrhovac, R.; Patkowska, E.; Kim, H.-J.; Zak, P.; Wang, P.-N.; Mitov, T.; Hanyok, J.; Liu, L.; Benzohra, A.; Lesegretain, A.; Cortes, J.; Perl, A.; Sekeres, M.; Dombret, H.; Amadori, S.; Wang, J.; Levis, M.; Schlenk, R.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. SAT0163 Defective autophagy in T lymphocytes from patients with systemic lupus erythematosus: Potential role of anti-lymphocyte autoantibodies. (23rd January 2014)

Authors:
Alessandri, C.; Pierdominici, M.; Conti, F.; Truglia, S.; Barbati, C.; Pendolino, M.; Vacirca, D.; Piscopo, P.; Maselli, A.; Colasanti, T.; Perl, A.; Ortona, E.; Malorni, W.; Valesini, G.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 71(2012)Supplement 3
Page Start:
526
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗